Robyn Fae Harbaugh, LPN | |
15931 Walnut St, Buchanan, MI 49107-9273 | |
(269) 409-8333 | |
Not Available |
Full Name | Robyn Fae Harbaugh |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 15931 Walnut St, Buchanan, Michigan |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124413091 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | 47039242A (Indiana) | Secondary |
164W00000X | Licensed Practical Nurse | 4703093643 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Robyn Fae Harbaugh, LPN 15931 Walnut St, Buchanan, MI 49107-9273 Ph: (269) 409-8333 | Robyn Fae Harbaugh, LPN 15931 Walnut St, Buchanan, MI 49107-9273 Ph: (269) 409-8333 |
News Archive
According to the latest report from the Centers for Disease Control and Prevention (CDC), the United States has had 118 measles cases so far this year, the most for this date since 1996, and close to 90% of them are linked to cases in other countries.
Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll professor and senior academic advisor to the dean, and Ira J. Gelb, M.D., emeritus professor of cardiology and senior advisor to the dean for pre-baccalaureate programs at FAU's Charles E. Schmidt College of Medicine, have published an invited editorial in the current issue of Cardiology about the clinical and public health challenges to increase utilization of statins in the treatment and prevention of heart attacks and strokes.
Harris Corporation recently introduced Harris CONNECT Engineering Support Services (CESS) to help healthcare organizations rapidly implement the Federal Heath Architecture CONNECT solution – a gateway to the Nationwide Health Information Network (NHIN).
Quinten, a strategic and operational consulting company specializing in the evaluation of biomedical data in the pharmaceutical, biotechnology and cosmetic industries, today announces the identification of two discriminating biological marker candidates which are indicative of a favorable response to treatment in women suffering from triple-negative breast cancer (TNBC).
› Verified 3 days ago